Eli

Long ACAD above $30. Target 31 and 35 in January.

Eli Updated   
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
4
ACAD in a money squeeze that appears to release soon to the upside coinciding with resistance break through. Daily MACD turned bullish and major MAs turning up. A good long idea upon confirmation of break out.
Trade active:
Breakout occurred and Price is back to the $30 breakout level, testing it as support. If support holds, go long still targeting $35. If support fails, 24 and 20 are downside targets.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.